Drug or technology
6 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 8, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a recruiting Phase 3 trial registration with no results posted; the study design and primary endpoints are defined but outcomes remain unreported.
SEP 8, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is an active Phase 3 trial registration with no results posted; the study design and primary endpoints are defined but efficacy and safety data are not yet available.
SEP 8, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
This is a Phase 2 trial registration with no reported results; the study is actively recruiting and outcome data are not yet available.
SEP 8, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is a Phase 1 study registration with no reported results, designed to characterize drug–drug interaction pharmacokinetics between an investigational agent and oral contraceptives in a small, defined population.
AUG 20, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
Phase 1 study of a novel gastrointestinal agent in a small, healthy volunteer population with pharmacokinetic endpoints; no efficacy or safety results reported in this registry record.
AUG 14, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
Phase 1 safety and tolerability study in a planned enrollment of 60 participants; no results posted; designed to characterize adverse events and pharmacokinetics rather than efficacy.